These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 6931549)

  • 21. Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Jan; 21(1):180-7. PubMed ID: 6979306
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin gentamicin.
    Braveny I; Machka K; Elsser R
    Infection; 1982 Jan; 10(1):45-9. PubMed ID: 6279523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-Formimidoyl thienamycin (MK0787): in-vitro antibacterial activity and susceptibility to beta-lactamases compared with that of cefotaxime, moxalactam and other beta-lactam antibiotics.
    Hanslo D; King A; Shannon K; Warren C; Phillips I
    J Antimicrob Chemother; 1981 Jun; 7(6):607-17. PubMed ID: 6265426
    [No Abstract]   [Full Text] [Related]  

  • 24. In-vitro activity of MK0787 (N-formimidoyl thienamycin) against Pseudomonas aeruginosa and other Gram-negative organisms and its stability to their beta-lactamases.
    Livermore DM; Williams RJ; Williams JD
    J Antimicrob Chemother; 1981 Nov; 8(5):355-62. PubMed ID: 6798011
    [No Abstract]   [Full Text] [Related]  

  • 25. Thienamycin: development of imipenen-cilastatin.
    Kahan FM; Kropp H; Sundelof JG; Birnbaum J
    J Antimicrob Chemother; 1983 Dec; 12 Suppl D():1-35. PubMed ID: 6365872
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Superior activity of N-formimidoyl thienamycin against gentamicin-resistant Pseudomonas aeruginosa.
    Michael PR; Alford RH; McGee ZA
    Antimicrob Agents Chemother; 1981 Nov; 20(5):702-4. PubMed ID: 6798926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of the in vitro spectrum of activity of imipenem.
    Jones RN
    Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro evaluation of N-formimidoyl thienamycin (MK0787) combined with amikacin against gram-negative bacilli and Staphylococcus aureus.
    Díez Enciso M; Mateos Lindemann M; Gutiérrez Altés A
    Antimicrob Agents Chemother; 1982 Dec; 22(6):1064-6. PubMed ID: 6818899
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative activities of 13 beta-lactam antibiotics.
    Muytjens HL; van der Ros-van de Repe J
    Antimicrob Agents Chemother; 1982 Jun; 21(6):925-34. PubMed ID: 7114839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods.
    O'Donnell ED; Freimer EH; Gilardi GL; Raeder R
    Antimicrob Agents Chemother; 1982 Apr; 21(4):673-5. PubMed ID: 6211143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.
    Rolfe RD; Finegold SM
    Antimicrob Agents Chemother; 1981 Nov; 20(5):600-9. PubMed ID: 7325628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity of 341 non-fermentative gram-negative bacteria to seven beta-lactam antibiotics.
    Appelbaum PC; Tamim J; Stavitz J; Aber RC; Pankuch GA
    Eur J Clin Microbiol; 1982 Jun; 1(3):159-65. PubMed ID: 7173181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [N-formimidoyl-thienamycin: in vitro activity in bacteria with resistance to beta-lactam antibiotics or gentamicin].
    Bartmann K; Tarbuc R
    Infection; 1982; 10(6):361-70. PubMed ID: 6818153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity and beta-lactamase stability of N-formimidoyl thienamycin compared to that of second and third generation cephalosporins.
    Vuye A
    Chemotherapy; 1982; 28(4):267-75. PubMed ID: 6981493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-formimidoyl-thienamycin and norfloxacin against multiple-resistant Pseudomonas aeruginosa strains. Combined in vitro activity and comparison with 14 other antibiotics.
    Martino P; Venditti M; Valente B; Brandimarte C; Serra P
    Drugs Exp Clin Res; 1985; 11(4):247-51. PubMed ID: 3939121
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative in-vitro activity of MK0787 (N-formimidoyl thienamycin) against 540 blood culture isolates.
    Cohn DL; Reimer LG; Reller LB
    J Antimicrob Chemother; 1982 Mar; 9(3):183-94. PubMed ID: 6210653
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of inducible beta-lactamase and antimicrobial resistance upon the activity of newer beta-lactam antibiotics against Pseudomonas aeruginosa.
    Hoffman TA; Cleary TJ; Bercuson DH
    J Antibiot (Tokyo); 1981 Oct; 34(10):1334-40. PubMed ID: 6796556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Imipenem (N-formimidoyl thienamycin): in vitro antimicrobial activity and beta-lactamase stability.
    Barry AL; Jones RN; Thornsberry C; Ayers LW; Kundargi R
    Diagn Microbiol Infect Dis; 1985 Mar; 3(2):93-104. PubMed ID: 3872196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The in vitro activity of N-formimidoyl thienamycin compared with other broad-spectrum cephalosporins and with clindamycin and metronidazole.
    Tischhauser G; Kayser FH
    Infection; 1983; 11(4):219-26. PubMed ID: 6578202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-formimidoyl thienamycin: in vitro comparison with cefoxitin and tobramycin against clinical, bacterial isolates.
    Digranes A; Dibb WL; Benonisen E
    Acta Pathol Microbiol Immunol Scand B; 1983 Apr; 91(2):141-4. PubMed ID: 6603093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.